Financhill
Back

ProShares UltraShort Nasdaq Biotech Vs. Globus Medical Industry Stock Comparison

Sell
20

BIS
ProShares UltraShort Nasdaq Biotech

Last Price:
17.59
Seasonality Move:
-10.36%
Buy
55

GMED
Globus Medical

Last Price:
65.85
Seasonality Move:
3.48%
Sell
20
ProShares UltraShort Nasdaq Biotech (BIS) is a Sell

Is ProShares UltraShort Nasdaq Biotech a Buy, Sell or Hold?

  • The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $17.59. The Score for BIS is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • BIS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
55
Globus Medical (GMED) is a Buy

Is Globus Medical a Buy, Sell or Hold?

  • The current Globus Medical [GMED] share price is $64.40. The Score for GMED is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • GMED is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BIS Stock Price Chart

What is ProShares UltraShort Nasdaq Biotech's stock price today?

  • The ProShares UltraShort Nasdaq Biotech share price today is $17.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIS is experiencing slight buying pressure.

GMED Stock Price Chart

What is Globus Medical's stock price today?

  • The Globus Medical share price today is $64.40
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GMED is experiencing buying pressure, which is a positive indicator for future bullish movement.

BIS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.43 Sell
Relative Strength Index (14 RSI): 38.43 Sell
Chaikin Money Flow: 580 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.93 - 20.33) Sell
Bollinger Bands (100): (17.19 - 19.11) Sell

GMED Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.4 Buy
Relative Strength Index (14 RSI): 73.03 Buy
Chaikin Money Flow: 629888 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.99 - 61.09) Buy
Bollinger Bands (100): (50.61 - 57.27) Buy

BIS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.86 Sell
20-day SMA: 18.77 Sell
50-day SMA: 18.66 Sell
200-day SMA: 20.25 Sell
8-day EMA: 17.84 Sell
20-day EMA: 18.4 Sell
50-day EMA: 18.62 Sell
200-day EMA: 19.59 Sell

GMED Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.79 Buy
20-day SMA: 56 Buy
50-day SMA: 53.88 Buy
200-day SMA: 52.21 Buy
8-day EMA: 62.23 Buy
20-day EMA: 58.17 Buy
50-day EMA: 55.17 Buy
200-day EMA: 54.04 Buy

ProShares UltraShort Nasdaq Biotech Earnings Growth & BIS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Globus Medical Earnings Growth & GMED Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.15 per share, an increase this year of $0.51 per share, and an increase next year of $0.49 per share.

ProShares UltraShort Nasdaq Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Globus Medical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):